Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients

<div>Clustered ranking plot of SUCRA values for efficacy vs. intolerability. AML, amlodipine; AZL, azilsartan; CAN, candesartan; FIM, fimasartan; LOS, losartan; TEL, telmisartan; PBO, placebo; S-AML, active enantiomer of amlodipine; CI, confidence interval.</div>

International Journal of Hypertension

fig4

Figure 4

Figure 4: Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients 

Figure 4 | Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients 